Form 4: Parabilis Medicines Director Receives Stock Grant
Insider Transaction (Form 4)
Craig Tendler, a Director of Parabilis Medicines, Inc., received 20,294 shares of common stock on August 22, 2026.
Summary
- Grant/award: acquired 20,294 Stock Option (Right to Buy) on August 22, 2026; holds 20,294 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Craig Tendler — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-22 | Grant/award | Stock Option (Right to Buy) | 20,294 | — | — | 20,294 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-22 | Grant/award (20,294 shares) |
Keywords
insider transaction, Form 4, PBLS, Parabilis Medicines, Inc., neutral, Craig Tendler
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.